Hello,

We noticed you're browsing in private or incognito mode.

To continue reading this article, please exit incognito mode or log in.

Not an Insider? Subscribe now for unlimited access to online articles.

Susan Young Rojahn

A View from Susan Young Rojahn

DNA Sequencing Detects Residual Leukemia

Genomic method is more sensitive than other techniques looking for lingering cells post-chemotherapy.

  • May 16, 2012

GenomeWeb Daily News reports that DNA sequencing is able to track cancerous blood cells in leukemia patients even when currently used methods cannot. The findings, published on May 16 in the journal Science Translational Medicine, suggest that high-throughput sequencing could improve the diagnosis and post-treatment monitoring of leukemia. The sequencing-based method is more sensitive than one of the two typical methods of detecting the malignant cells (flow cytometry) and cheaper and faster than the other (quantitative real-time PCR).

GenomeWeb notes that the Fred Hutchinson Cancer Research Center, one of the research institutions involved in the study, has applied for patents related to the technique.

More from Rewriting Life

Reprogramming our bodies to make us healthier.

Want more award-winning journalism? Subscribe to Insider Plus.
  • Insider Plus {! insider.prices.plus !}*

    {! insider.display.menuOptionsLabel !}

    Everything included in Insider Basic, plus the digital magazine, extensive archive, ad-free web experience, and discounts to partner offerings and MIT Technology Review events.

    See details+

    What's Included

    Unlimited 24/7 access to MIT Technology Review’s website

    The Download: our daily newsletter of what's important in technology and innovation

    Bimonthly print magazine (6 issues per year)

    Bimonthly digital/PDF edition

    Access to the magazine PDF archive—thousands of articles going back to 1899 at your fingertips

    Special interest publications

    Discount to MIT Technology Review events

    Special discounts to select partner offerings

    Ad-free web experience

/3
You've read of three free articles this month. for unlimited online access. You've read of three free articles this month. for unlimited online access. This is your last free article this month. for unlimited online access. You've read all your free articles this month. for unlimited online access. You've read of three free articles this month. for more, or for unlimited online access. for two more free articles, or for unlimited online access.